PB2089: ALGORITHM FOR SEVERE COVID‐19 RISK STRATIFICATION DEPENDING MONOCLONAL ANTI‐CD20 ANTIBODIES TREATMENT DURATION IN NON‐HODGKIN LYMPHOMA PATIENTS.

Autor: Sychevskaya, K., Kravchenko, S., Babaeva, F., Misyurina, A., Korneeva, A., Abdulpatahov, A., Abdurashidova, R., Keniaykina, A., Sarakaeva, Z., Fastova, E., Gorenkova, L., Nesterova, E., Mangasarova, Y., Bagova, M., Margolin, O., Magomedova, A.
Zdroj: HemaSphere; 2022 Supplement 3, Vol. 6, p1960-1961, 2p
Databáze: Complementary Index
Externí odkaz: